Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOT VAC | VAC | 3.27% |
| BLOOMIN BRAN | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Lower domestic product sales coupled with decline in product orders before the crucial holiday season led Malibu, California-based JAKKS Pacific Inc. (JAKK - Analyst Report) to slash its sales and earnings outlook for fiscal 2012. The company also had to bear the brunt of higher costs, including marketing and advertising expenses as well as minimum license royalty guarantees.
For 2012, the company lowered its net sales forecast to the range of $690—$700 million from the previous range of $720–-$728 million and adjusted earnings guidance to 68—74 cents from the earlier projection of $1.04 and $1.08 per share, excluding the legal and financial advisory charges. On a GAAP basis, JAKKS Pacific anticipates to finish 2012 in the range of a loss of $2.77 to earnings of 74 cents.
Management is apprehensive about the remainder of 2012 based on a host of factors which include tough retail environment, cost inflation, increased pricing pressures, and higher costs for many manufacturers operating in Asia affecting production and shipment.
The Zacks Consensus Estimate for the third quarter and fiscal 2012 are pegged at $1.43 and 52 cents, respectively. We expect estimates to go down in the coming days as the company reduced its fiscal 2012 guidance based on its weak retail sales prior to the upcoming holiday season.
Earlier, management remained upbeat on its product line-up driven by Monsuno, an animated Japanese television series, as well as a toy-line and Winx Club, an eminent fashion doll in European markets. However, the expectation does not seem to come into fruition.
JAKKS, which competes with Mattel Inc. (MAT - Analyst Report) and Hasbro Inc. (HAS - Analyst Report), is expected to report its third quarter 2012 results on October 15, 2012.
JAKKS Pacific currently carries a Zacks #3 Rank, which translates into a short-term Hold rating. We are also maintaining our long-term Neutral recommendation on the stock.
Read the full reports :
Analyst Report on JAKK
Analyst Report on HAS
Analyst Report on MAT